PCSK9 inhibitor causes a reduction in the level of oxidatively modified low-density lipoproteines in patients with atherosclersosis
author
Lankin, Vadim Z.
Tikhaze, Alla K.
Chazova, Irina
Viigimaa, Margus
statement of authorship
Vadim Lankin, Alla Tikhaze, Irina Chazova, Margus Viigimaa
source
7th Baltic Atherosclerosis Society Congress : [abstracts]
location of publication
[Tallinn]
publisher
[Celsius Healthcare]
year of publication
2018
pages
p. 38-39
series
Eesti Arst ; vol. 97, 2018 : lisa
conference name, date
7th Baltic Atherosclerosis Society Congress, April 6-7, 2018
conference location
Tallinn, Estonia
url
http://www.ester.ee/record=b4819912*est
subject term
kolesterool
inhibiitorid
ateroskleroos
ISSN
0235-8026
TTÜ department
tervisetehnoloogiate instituut
language
inglise